AZ research collaboration targets cancer ‘chaperones’
June 8, 2009Research and Development AZ, Academic
AstraZeneca is putting more than £4 million over the next three years into an oncology research project with two partners. …
Time running out for biotech
June 5, 2009Research and Development biotech
The funding crisis which is paralysing the global biotech sector sees no sign of abating, and more and more companies …
Kiernan agency to focus on opinion leader strategy
June 5, 2009Medical Communications Expert Health
The former managing director of GCI Health has set up a communications agency aimed at pharma companies and other healthcare …
Ambassadors’ sought for ambitious engagement plan
June 5, 2009Sales and Marketing ABPI
People from across the industry are being asked to volunteer as 'ambassadors' for the pharma sector to conduct a large-scale …
NICE and MRC to research watchdog’s methodology
June 5, 2009NICE
Funding worth £2 million has been made available for research into how NICE can better do its job. The drug …
Embracing marketing excellence
June 4, 2009Sales and Marketing excellence, marketing
Since 2000, the top 15 pharmaceutical companies have lost around $800 billion in shareholder value, and looking forward, drug patent …
Genzyme buys rights to Bayer MS candidate
June 4, 2009Sales and Marketing Bayer, Genzyme
Genzyme has bought the global rights multiple sclerosis (MS) candidate Campath/MabCampath from Bayer HealthCare.Originally discovered by Genzyme, Campath (alemtuzumab) is …
Takeda delays diabetes drug in Europe
June 4, 2009Research and Development, Sales and Marketing Takeda, diabetes
Takeda is to delay seeking European approval of its key drug candidate alogliptin, and instead take another two years to …
FDA to improve transparency
June 3, 2009Research and Development FDA, US
The US medicines regulator is to boost the transparency around its decision-making, in connection with President Obama's aim to make …
AstraZeneca and Merck launch early stage trial collaboration
June 3, 2009Research and Development AZ, AstraZeneca, Cancer, Merck
Merck and AstraZeneca have begun an unprecedented collaboration to bring together the clinical trials of two early stage cancer medicines.The …
US health industry outlines cost saving plans
June 3, 2009Sales and Marketing US, US healthcare, healthcare, industry
The US healthcare industry has said how it contribute to President Obama’s drive to cut healthcare costs, and help save …
Pfizer offers to sell drugs plant to Venezuela
June 3, 2009Manufacturing and Production Pfizer, Venezuela
US drugmaker Pfizer has been in emergency talks with the government of Venezuela after being threatened with seizure of a …
Contract research sector: news in brief
June 2, 2009Research and Development CRO
Pharmafocus presents a round-up of developments in the contract research sector, including a merger between etrials and Merge, new contracts …
INC snaps up MDS’ late-stage clinical ops
June 2, 2009Research and Development mds
Canadian life sciences company MDS has offloaded part of its pharmaceutical services division to INC Research in a $50 million …
Can European biotech stay afloat?
June 1, 2009Research and Development biotech, economic climate, funding, investment
For the European biotech industry, the last few years have seen sustained growth across several fronts – much-needed progress after …
NICE approves Erbitux for colon cancer
June 1, 2009Research and Development, Sales and Marketing Erbitux, NICE
NICE has approved Merck Serono's Erbitux, making it a first-line therapy for many patients with a certain type of metastatic …
Companies poised for swine flu vaccine drive
May 29, 2009Research and Development, Sales and Marketing US, h1n1, vaccines
Pharmaceutical manufacturers now have access to the swine flu seed virus that can be used to start full-blown production of …
Latest content
